Cargando…

Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015–2017

BACKGROUND: The molecular characteristics of carbapenem-resistant Escherichia coli (CREco) remain unclear. METHODS: We conducted a multi-center bacterial resistance monitoring project from 2015 to 2017.The minimum inhibitory concentrations ofCREco were determined bybroth microdilution method. The ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fengtian, Ye, Kun, Li, Xin, Ye, Liyan, Guo, Ling, Wang, Lifeng, Yang, Jiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449468/ https://www.ncbi.nlm.nih.gov/pubmed/34535075 http://dx.doi.org/10.1186/s12866-021-02307-x

Ejemplares similares

Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
por: Chang, Ya-Ting, et al.
Publicado: (2019)

Genetic characterization of bla(NDM)-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar
por: Sugawara, Yo, et al.
Publicado: (2017)

Isolation and Characterization of Carbapenem-Resistant Escherichia coli Carrying bla(NDM) and mcr-1 from Recurrent Urinary Tract Infection Patient
por: Chen, Liang, et al.
Publicado: (2023)

Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017
por: Peirano, Gisele, et al.
Publicado: (2022)

Genomic Analysis of KPC-2-Producing Klebsiella pneumoniae ST11 Isolates at the Respiratory Department of a Tertiary Care Hospital in Beijing, China
por: Guo, Ling, et al.
Publicado: (2022)

Correction: Genetic characterization of bla(NDM)-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar
Publicado: (2017)

Prevalence and molecular epidemiology characteristics of carbapenem-resistant Escherichia coli in Heilongjiang Province, China
por: Cheng, Ping, et al.
Publicado: (2019)

Characterization of a Novel NDM-5-Harboring Plasmid from a Carbapenem-Resistant Escherichia coli Isolate from China
por: Yin, Dongdong, et al.
Publicado: (2020)

Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Escherichia coli Isolated from Chinese Patients During 2002–2017
por: Tian, Xuebin, et al.
Publicado: (2020)

Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon
por: Dagher, Christel, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People’s Democratic Republic
por: Cusack, Tomas-Paul, et al.
Publicado: (2019)

Phenotypic and Genotypic Characterization of Carbapenem-Resistant Enterobacteriaceae Recovered from a Single Hospital in China, 2013 to 2017
por: Zhang, Yan, et al.
Publicado: (2022)

Genome Assessment of Carbapenem- and Colistin-Resistant Escherichia coli from Patients in a Sentinel Hospital in China
por: Ma, Jiangang, et al.
Publicado: (2022)

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli
por: Kim, Hye-Rim, et al.
Publicado: (2021)

Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli
por: Bharathan, Subhashree, et al.
Publicado: (2019)

Occurrence of High Levels of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli before Its Approval in China: a Report from China CRE-Network
por: Wang, Qi, et al.
Publicado: (2022)

Molecular epidemiology and genomic insights into the transmission of carbapenem-resistant NDM-producing Escherichia coli
por: Xu, Juan, et al.
Publicado: (2023)

High Prevalence of bla(NDM) Variants Among Carbapenem-Resistant Escherichia coli in Northern Jiangsu Province, China
por: Bi, Ruru, et al.
Publicado: (2018)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

Characteristics of Carbapenem-Resistant and Colistin-Resistant Escherichia coli Co-Producing NDM-1 and MCR-1 from Pig Farms in China
por: Peng, Zhong, et al.
Publicado: (2019)

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli
por: Jin, Hye-Won, et al.
Publicado: (2022)

In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China
por: Huang, Na, et al.
Publicado: (2021)

Clinical Distribution Characteristics of 1439 Carbapenem-Resistant Escherichia coli Strains in China: Drug Resistance, Geographical Distribution, Antibiotic MIC50/90
por: Zhang, Wei, et al.
Publicado: (2021)

Nosocomial spread of OXA-232-producing Klebsiella pneumoniae ST15 in a teaching hospital, Shanghai, China
por: Li, Xin, et al.
Publicado: (2019)

Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli
por: Atzori, Alessio, et al.
Publicado: (2020)

Risk factors and outcome associated with infection or colonization due to carbapenem-heteroresistant Escherichia coli
por: Tan, Karen, et al.
Publicado: (2021)

The Resistance Mechanism Governs Physiological Adaptation of Escherichia coli to Growth With Sublethal Concentrations of Carbapenem
por: Schäfer, Franca, et al.
Publicado: (2022)

Prevalence of main quinolones and carbapenems resistance genes in clinical and veterinary Escherichia coli strains
por: Karshenas, Ali Ehsan, et al.
Publicado: (2022)

Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China
por: Chen, Yili, et al.
Publicado: (2020)

Molecular characterization of clinical IMP-producing Klebsiella pneumoniae isolates from a Chinese Tertiary Hospital
por: Lai, Kaisheng, et al.
Publicado: (2017)

Construction and Characterization of an Escherichia coli Mutant Producing Kdo(2)-Lipid A
por: Wang, Jianli, et al.
Publicado: (2014)

Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010–2015 in a Tertiary Hospital, Shanghai, China
por: Li, Dan, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
por: Jitaree, Kamonchanok, et al.
Publicado: (2019)

Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring bla(NDM-1) in an IncC plasmid
por: Tello, Maitane, et al.
Publicado: (2021)

Phenotypic and Molecular Characterization of Carbapenems Resistant Escherichia coli Isolated from Patients with Urinary Tract Infections in Ardabil Province, Iran
por: khavandi, Shabnam, et al.
Publicado: (2022)

Characterization of Genomic Diversity among Carbapenem-Resistant Escherichia coli Clinical Isolates and Antibacterial Efficacy of Silver Nanoparticles from Pakistan
por: Gondal, Aamir Jamal, et al.
Publicado: (2022)

Label-free identification carbapenem-resistant Escherichia coli based on surface-enhanced resonance Raman scattering
por: Li, Jia, et al.
Publicado: (2018)

Elimination of bla(KPC−2)-mediated carbapenem resistance in Escherichia coli by CRISPR-Cas9 system
por: Tao, Shuan, et al.
Publicado: (2023)

Epidemiology of Enterotoxigenic Escherichia coli infection in Minnesota, 2016–2017
por: Buuck, S., et al.
Publicado: (2020)

Increased prevalence of Escherichia coli strains from food carrying bla (NDM) and mcr-1-bearing plasmids that structurally resemble those of clinical strains, China, 2015 to 2017
por: Liu, Xiaobo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e1qlrd8nafo4flj9etrci0ldgh